Exploring Key Insights of the Inactivated Vaccines Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the Inactivated Vaccines Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
The market size for inactivated vaccines has been consistently increasing in the last few years. It is expected to rise from $6.19 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 4.0%. The expansion during the historical timeframe was propelled by initiatives aimed at eradicating polio, influenza immunization schemes, the emergence of infectious diseases, and regulatory approvals.
The market size for deactivated vaccines is predicted to experience consistent expansion in the upcoming years, reaching a value of $7.75 billion in 2029 with a compound annual growth rate (CAGR) of 4.7%. This growth during the forecast period is due to preparedness for pandemics, increased vaccine coverage, advancements in biomanufacturing, and initiatives for health equity. Significant trends during this period are expected to include mRNA vaccine platforms, combined vaccines, thermostable vaccines, and digital vaccine passports.
What Drivers Are Shaping the Growth of the inactivated vaccines Market?
The rise in infectious diseases is anticipated to catalyze the growth of the inactivated vaccine industry in the coming years. These diseases, caused by pathogens like bacteria, viruses, fungi, or parasites, can be easily transmitted from one person to another, leading to a variety of symptoms and health issues. Tuberculosis, for example, is a common infectious disease. Inactivated vaccines employ dead pathogens to trigger an immune response, which helps prevent diseases such as polio, hepatitis A, and influenza. As per an article from the US-based Centers for Disease Control and Prevention in November 2023, the count of tuberculosis patients in the USA had surged from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Consequently, the escalating prevalence of infectious diseases is fueling the expansion of the inactivated vaccine market.
Growth of Inactivated Vaccines Market Through Increasing Immunization Initiatives
Get Your Free Sample of the Global Inactivated Vaccines Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
Which Key Players Are Shaping the Future of the Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are:
• Pfizer Inc._x000D_
• Johnson & Johnson Services Inc._x000D_
• Sinopharm Group Co. Ltd._x000D_
• Merck & Co. Inc._x000D_
• Sanofi S.A._x000D_
How Are the Latest Trends Influencing the Growth of the Inactivated Vaccines Market?
Leading firms in the inactivated vaccines market are striving to maintain their market presence by launching advanced and innovative inactivated vaccines. These vaccines consist of inactivated virus particles, bacteria, or other pathogens, which are cultured and subsequently killed to eliminate the disease-causing ability. For example, the UK-headquartered pharmaceutical and biotechnology firm, GSK PLC, launched an innovative inactivated vaccine called Shingrix in January 2022, aimed at improving protection against shingles (Herpes zoster). Shingrix, an intramuscularly administered non-live, recombinant subunit adjuvanted vaccine, was initially indicated for individuals aged 50 years and above. More recently, the scope of Shingrix has been widened to include individuals aged 18 and above who are at an increased risk of getting shingles due to immunosuppression or immunodeficiency associated with specific illnesses or treatments.
Get Instant Access to the Global Inactivated Vaccines Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Which Market Segments Are Driving Strategic Growth and Trends in the Inactivated Vaccines Market?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
What Regions Are At the Forefront of Inactivated Vaccines Market Expansion?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Can We Define the Inactivated Vaccines Market and Its Key Components?
Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
